Get the Stockscreener App
0.8961
0.91%
-0.0013
After Hours:
.89
-0.0061
-0.68%
Biofrontera Inc stock is traded at $0.8961, with a volume of 81,134.
It is down -0.91% in the last 24 hours and down -0.09% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$0.8948
Open:
$0.9235
24h Volume:
81,134
Relative Volume:
0.19
Market Cap:
$10.44M
Revenue:
$39.19M
Net Income/Loss:
$-16.59M
P/E Ratio:
-0.4107
EPS:
-2.182
Net Cash Flow:
$-9.39M
1W Performance:
-3.15%
1M Performance:
-0.09%
6M Performance:
+5.70%
1Y Performance:
+5.02%
1-Day Range:
$0.8602
$0.9235
1-Week Range:
$0.8573
$0.95
52-Week Range:
$0.536
$1.19
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.8961 | 10.42M | 39.19M | -16.59M | -9.39M | -2.182 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.98 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.48 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.88 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Biofrontera Inc Stock (BFRI) Latest News
BFRIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Biofrontera Inc. stock go up in YEAR2025 Top Gainers & Risk Controlled Stock Alerts - mfd.ru
Bank Watch: Is Biofrontera Inc a play on infrastructure spendingJuly 2025 Final Week & AI Enhanced Execution Alerts - baoquankhu1.vn
Biofrontera wins patent ruling against Sun Pharma in dispute - Investing.com
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims - TipRanks
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute - TipRanks
Biofrontera wins patent ruling against Sun Pharma in dispute By Investing.com - Investing.com UK
Biofrontera (NASDAQ: BFRI) wins PTAB decision on Sun Pharma patent claims - Stock Titan
U.S. patent board backs Biofrontera in battle over Sun Pharma patent - Stock Titan
Gains Recap: Will Biofrontera Inc stock go up in YEAR2025 Trading Recap & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock technically oversoldWeekly Stock Analysis & Community Consensus Trade Signals - mfd.ru
Growth Value: Can Biofrontera Inc Equity Warrant sustain its profitabilityLong Setup & Weekly Breakout Watchlists - baoquankhu1.vn
Trading Action: Does Biofrontera Inc have high return on assets2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Can Biofrontera Inc Equity Warrant sustain its profitabilityMarket Growth Report & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
How Biofrontera Inc. Equity Warrant stock responds to policy changesJuly 2025 Retail & Low Drawdown Momentum Ideas - mfd.ru
Fundamentals Check: Can Biofrontera Inc Equity Warrant navigate macro headwindsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Biofrontera completes key study for Ameluz skin treatment expansion By Investing.com - Investing.com South Africa
Biofrontera Emerges as Stronger Biotech Stock Compared to RenovaCare - National Today
Biofrontera completes key study for Ameluz skin treatment expansion - Investing.com
Biofrontera Inc (NASDAQ: BFRI) recently announced that the database lock for its Phase I pharmacokinetic study of Ameluz® for actinic keratosis on the trunk and extremities has been completed. - Bitget
Biofrontera Inc. Announces Database Lock of Phase 1 - GlobeNewswire
Travel Stocks: Does Biofrontera Inc have a sustainable dividend2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
Biofrontera reports positive phase 3 data for Ameluz in actinic keratosis - MSN
Bull Run: Is now the right time to enter Biofrontera Inc Equity Warrant - baoquankhu1.vn
BFRI SEC FilingsBiofrontera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Fundamentals Check: Why ETFs are accumulating Biofrontera AG (B8FK) stockJuly 2025 PostEarnings & Stepwise Trade Execution Plans - mfd.ru
Signal Recap: Is Biofrontera Inc stock a hidden gemTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock near bottom after declineMarket Trend Review & AI Forecast Swing Trade Picks - mfd.ru
Biofrontera Inc. (NASDAQ:BFRI) Sees Significant Decline in Short Interest - Defense World
Will Biofrontera Inc. Equity Warrant benefit from AI trendsDollar Strength & Scalable Portfolio Growth Methods - mfd.ru
Biofrontera announces FDA filing acceptance of supplemental new drug application for Ameluz® PDT in superficial Basal Cell Carcinoma - marketscreener.com
Biofrontera Announces FDA Filing Acceptance of Supplemental - GlobeNewswire
Biofrontera’s Ameluz shows strong results in actinic keratosis trial By Investing.com - Investing.com Australia
Biofrontera announces positive results in phase 3 study of Ameluz® PDT - marketscreener.com
Biofrontera Reports Positive Phase 3 Ameluz PDT Results - TipRanks
Biofrontera’s Ameluz shows strong results in actinic keratosis trial - Investing.com
Light therapy gel clears more actinic keratoses on limbs, neck - Stock Titan
Biofrontera (NASDAQ:BFRI) Trading Down 5.6% – Here’s What Happened - Defense World
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Finviz
Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Trading Action: What are the future prospects of Biofrontera IncEarnings Beat & Verified Short-Term Trading Plans - baoquankhu1.vn
Earnings Miss: Will Biofrontera Inc stock go up in YEARJuly 2025 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Selloffs: Is Pitney Bowes Inc Preferred Security a turnaround story2025 Support & Resistance & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Published on: 2026-01-27 12:03:44 - baoquankhu1.vn
Aug Catalysts: Can Biofrontera Inc stock outperform in a bear marketJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Big Picture: Can Biofrontera Inc Equity Warrant sustain its profitabilityEarnings Recap Summary & Real-Time Price Movement Reports - baoquankhu1.vn
There's No Escaping Biofrontera Inc.'s (NASDAQ:BFRI) Muted Revenues Despite A 42% Share Price Rise - Sahm
Portfolio Update: Is Root Inc part of any major index2025 Fundamental Recap & Reliable Price Breakout Signals - baoquankhu1.vn
Update Recap: Is Brighthouse Financial Inc attractive at current valuationWeekly Profit Report & Capital Efficient Trade Techniques - baoquankhu1.vn
Merger Talk: Does Biofrontera Inc Equity Warrant stock reflect fundamentals2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn
Can Biofrontera Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Closing Moves & Technical Buy Zone Confirmations - bollywoodhelpline.com
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):